Katherine Stueland
Chief Executive Officer at GeneDx Holdings Corp.
Sits on 1 board. Last updated September 27, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: GeneDx Holdings Corp., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
GeneDx Holdings Corp. June 18, 202675.7%
-
GeneDx Holdings Corp. June 14, 202377.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 16, 2026 | GeneDx Holdings Corp. | Option exercise | +18,750 | — | — |
| Sep 16, 2026 | GeneDx Holdings Corp. | Open-market sale | −1,648 | $94.26 | $155,337 |
| Sep 16, 2026 | GeneDx Holdings Corp. | Open-market sale | −148 | $95.41 | $14,120 |
| Sep 16, 2026 | GeneDx Holdings Corp. | Open-market sale | −1,525 | $96.90 | $147,774 |
| Sep 16, 2026 | GeneDx Holdings Corp. | Open-market sale | −4,141 | $98.27 | $406,936 |
| Sep 16, 2026 | GeneDx Holdings Corp. | Open-market sale | −3,039 | $99.00 | $300,846 |
| Sep 9, 2026 | GeneDx Holdings Corp. | Option exercise | +6,547 | — | — |
| Sep 9, 2026 | GeneDx Holdings Corp. | Open-market sale | −3,692 | $84.22 | $310,932 |
| Jun 16, 2026 | GeneDx Holdings Corp. | Option exercise | +18,750 | — | — |
| Jun 16, 2026 | GeneDx Holdings Corp. | Open-market sale | −2,140 | $59.75 | $127,865 |
| Jun 16, 2026 | GeneDx Holdings Corp. | Open-market sale | −5,932 | $60.83 | $360,844 |
| Jun 16, 2026 | GeneDx Holdings Corp. | Open-market sale | −2,429 | $61.50 | $149,384 |
| Jun 9, 2026 | GeneDx Holdings Corp. | Option exercise | +6,546 | — | — |
| Jun 9, 2026 | GeneDx Holdings Corp. | Open-market sale | −3,639 | $53.77 | $195,669 |
| Apr 29, 2026 | GeneDx Holdings Corp. | Option exercise | +3,874 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.